Insider Shareholders with Direct Ownership of Inhibitor Therapeutics, Inc. (INTI)
This section provides a comprehensive overview of the insiders with direct ownership of Inhibitor Therapeutics, Inc. (INTI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Inhibitor Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Mayne Pharma Ventures Pty Ltd
> 10% Shareholder |
2,240,488 | 0 | 204,083,227 $14.3 Million | 1 |
Jan 15, 2021
Added 1.09%
|
|
Ronald E Osman
Director |
25,000 | 0 | 23,514,985 $1.65 Million | 1 |
Aug 11, 2023
Added 0.11%
|
|
Samuel P Sears Jr
Director |
50,000 | 0 | 1,129,543 $79,068 | 1 |
Apr 01, 2024
Added 4.24%
|
|
Michelle Yanez
Director |
846,271 | 0 | 896,271 $62,738 | 2 |
Apr 01, 2024
Added 5.28%
|
|
Michael Allen Jerman
Director |
50,000 | 0 | 80,411 $5,628 | 1 |
Apr 01, 2024
Added 38.34%
|
|
James A Mcnulty
CHIEF FINANCIAL OFFICER |
398,135 | 0 | 0 $0 | 1 |
N/A
|